Nuvalent jumps after GSK's $10.6 bln acquisition deal
09/06/2026 10:14
BUZZ-Nuvalent jumps after GSK's $10.6 bln acquisition deal ** Shares of cancer drugmaker Nuvalent NUVL.O jump 38.4% to $122.56 premarket
** Drugmaker GSK GSK.L agrees to buy NUVL for $10.6 bln
** The all-cash deal values NUVL at $124 per share, a 40% premium to its Monday's closing price of $88.49
** Deal is expected to close in the third quarter of 2026
** GSK shares down 3.5% at 1,846 p
** Up to last close NUVL shares were down ~12%, YTD
(Reporting by Avinash P inbenglauru)